Taken together, epidemiological data emerging from the COVID-19 pandemic, backed by animal studies and further by preliminary clinical studies in diverse clinical settings, support the notion that high (male) testosterone levels acting via the AR modulate TMPRSS2 function positively to further prime SARS-CoV-2 S proteins and eventually increase COVID-19 infectivity and severity. Here, TMPRSS2 is linked to COVID-19.